The State of the Life Sciences Industry

If you have been wondering what the United States’ new administration means to pharmaceutical, biotechnology, and medical device companies, many headlines suggest that it would, in fact, be very good to them. It could result in more mergers and acquisitions, increased innovation, and a reformed FDA.

In this guide, we explore some key issues and perspectives from industry executives that have the potential to significantly impact the life sciences industry in 2017 and beyond.